Abstract:Abstract Background and Aims Copper is a trace element essential for numerous biological activities, whereas the mitochondria serve as both major sites of intracellular copper utilization and copper reservoir. Pyruvate dehydrogenase complex (PDHC) is a rate-limiting enzyme of glucose oxidation in mitochondrial matrix, converting pyruvate into acetyl-CoA and linking glycolysis to tricarboxylic acid (TCA) cycle. Dihydrolipoamide acetyltransferase (DLAT), the E2 component of the PDHC, requires lipoylation for enzymatic function and exhibits a high affinity for copper within its lipoyl moiety. Here, we investigated the impact of mitochondrial copper overload on the tricarboxylic acid cycle and renal senescence and fibrosis. Method Molecular dynamics simulation was used to explore the effect of copper ions on lipoylated DLAT protein. ICP-MS was used to detect copper content in mitochondria. Western blotting was used to detect the level of lipoylated DLAT dimer. Enzyme biopsy test kit, electron microscopy, mitoSOX Red staining and ATP content detection were used to evaluate mitochondrial function. Detect Collagen I, α-smooth muscle actin (α-SMA) expression levels and Masson staining to explore renal fibrosis. To reduce mitochondrial copper level, we used lentivirus to downregulate CRT1 expression or copper chelator tetrathiomolybdate in renal tubular epithelial cells (NRK-52E), and used CTR1 knockdown transgenic mice or tetrathiomolybdate in vivo. Results We found that copper ion levels are significantly elevated in the mitochondria in fibrotic kidney tissues, which are accompanied by reduced pyruvate dehydrogenase (PDH) activity, mitochondrial dysfunction, cellular senescence and renal fibrosis. Conversely, lowering mitochondrial copper levels through knocking-down of copper transporter 1 or treatment with the copper chelator tetrathiomolybdate effectively restore PDH enzyme activity, improve mitochondrial function, and mitigate cellular senescence and renal fibrosis. Mechanically, we found mitochondrial copper binds directly to lipoylated dihydrolipoamide acetyltransferase (DLAT), thereby changing the interaction between protein subunits, inducing lipoylated DLAT protein dimerization, and ultimately inhibiting PDH enzyme activity. Conclusion Our study indicates that mitochondrial copper overload could inhibit PDH activity, subsequently leading to mitochondrial dysfunction, cellular senescence and renal fibrosis. Reducing mitochondrial copper overload might therefore serve as a strategy to rescue renal fibrosis.

Effect of pcDNA3.1(+)/ATP7B on Copper Metabolism of Fibroblast of TX Mouse

Effect of copper metabolism of pcDNA3.0/ATP7B on TX mice

Effects of pcDNA3.0/ATP7B on Liver Function of TX Mice

Reduced 64cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer.

Effect of Mini Ad-ATP7B-GFP on the Copper Metabolism of Skin Fibroblasts of Wilson′s Disease Patients

Expression of recombinant BC047440 protein and its effects on proliferation of HepG2 cells in vitro

Identification of High-Copper-responsive Target Pathways in Atp7b Knockout Mouse Liver by GSEA on Microarray Data Sets.

ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson’s disease

Tongxinluo Inhibits Palmitic Acid-Induced Apoptosis of Human Endothelial Progenitor Cells by Down——regulating Expression and Activity of Caspase-3 Protein

Functional analyses of copper transporter genes in the human liver cell line HepG2

ATP7A-dependent Copper sequestration contributes to termination OF β-CATENIN SIGNALING DURING EARLY ADIPOGENESIS

ATPase Copper Transporting Beta (ATP7B) is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer.

Copper transporter gene ATP7A: A predictive biomarker for immunotherapy and targeted therapy in hepatocellular carcinoma

#2036 Mitochondrial copper overload promotes renal fibrosis via inhibiting pyruvate dehydrogenase activity

Construction of site-directed mutant variants of ATP7B in vitro and their expression

Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis

In Situ Transformable Fibrillar Clusters Disrupt Intracellular Copper Metabolic Homeostasis by Comprehensive Blockage of Cuprous Ions Efflux

Abstract 1687: ATPase copper transporting beta (ATP7B) contributes to acquired docetaxel resistance in human prostate cancer

Supplementary Figure 2 from ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer

Study of Copper Metabolism and Liver Damage in TX Mice-an Animal Model for Liver Disease